Discussion on Severe Complications After Interventional Treatment of Cardiovascular Diseases

Objective: To investigate the serious complications after interventional therapy of clinical cardiovascular disease. Methods: 400 patients with cardiovascular disease who received interventional therapy in our hospital from March 2020 to May 2022 were selected, among which 30 patients had serious complications after receiving interventional therapy. This study and 30 patients with complications were taken as research objects, and the specific status of treatment and complications of all patients were statistically studied. Results: The statistical analysis showed that the complication rate was 9.32% in the elective cardiac group, 7.92% in the emergency cardiac group, and 6.52% in the vascular group. The incidence of serious complications in the elective group was significantly higher than that in the other groups (P < 0.05). The clinical manifestations of serious complications after interventional therapy of cardiovascular diseases were severe arrhythmia, hematoma at puncture point, anaphylactic shock at contrast dose, etc. The incidence of these three clinical symptoms were 23.33%, 16.67%, 16.67%, respectively, and compared with other clinical symptoms, the difference was significant (P < 0.05). Conclusion: Puncture point hematoma, arrhythmia and contrast anaphylactic shock are common complications after interventional therapy of clinical cardiovascular diseases. Attention should be paid to the interventional therapy and effective countermeasures should be taken to effectively control the incidence of complications and mortality.